Haploidentic Bone Marrow Transplantation

Haploidentical transplantation:

In this type of transplantation, donor is a relative of patient who is not fully compatible.

It is a good alternative for patients who has no fully HLA-compatible donor. Fully compatible donor should be preferred, but if there is no such donor, partially compatible related donor should be considered. The consequence of this method in patients, who have not a chance to spend time searching for a non-related donor, is as successful as other transplantation methods. The most important disadvantage of haploidentical transplantation is higher risk of infection (since there is a significant antigen incompatibility). Therefore, it is necessary to monitor infections very carefully and take protective measures timely.

If a donor is searched for allogeneic stem cell transplantation, tissue groups of siblings, if available, are first analyzed. If no fully compatible donor can be found among siblings, close relatives of patient can be screened and final option will be “bone marrow banks”, if screening result is negative. It may take 2 to 10 months to search for a compatible donor from bone marrow banks.

Patient is first given high-dose chemotherapy in allogeneic stem cell transplantation, similar to autologous stem cell transplantation. Next, stem cells collected from a healthy donor (sibling, related or non-related) are transplanted to the patient. These stem cells enable production of healthy blood cells in bone marrow of the patient.

In allogeneic stem cell transplantation, “Graft versus host disease”(GvHD) is a possible risk that is secondary to tissue incompatibility between donor and patient. GvHD is a serious disease that can cause severe damage in organs of recipient. Therefore, it is critically important that patient and donor are fully compatible to the maximum extent possible.

Bone marrow is responsible for synthesis of cells that are needed for life and for coping with harmful factors and results. Uncontrolled or false synthesis or inability to synthesize these cells may result with diseases.

After these diseases occur, hematopoetic stem cell transplantation can be sometimes required due to recurrence of disease, even if recoveries can be achieved with various medical therapies, and/or inability to achieve recovery or need to high-dose chemotherapy in order to achieve recovery.

One should always remember that in bone marrow transplantations, patients are vulnerable to infection and sometimes bleeding. Generally, almost all patients who undergo allogeneic transplantation use immunosuppressive drugs and thus, one should be very careful for both risks of infection and drug interactions in other therapies.

While these risks are highly possible in allogeneic transplantations, there are short-term risks in autologous transplantations as no immunosuppressive drug is used. The compliance between stem cell of donor and tissue of patient is ensured with various immunosuppressive therapies.

Related articles

Regenera Activa

Our Medical Aesthetic Specialist Dr. Mehmet Faruk Yavuz and his valuable guests Dr. Rafael Galvez and Dr. Pietro Gentile are informing about Regenera Activa Therapy.

4478 Times viewed

F.A.Q. about Organ Transplantation

Transplantation is the moving of an tissue or organ from one body to another (or from a donor site on the patient's own body), for the purpose of replacing the recipient's damaged or failing organ with a working one from the donor site as a treatment option. It can be done by operation or other ways.

6938 Times viewed

Organ Transplantation

Organs for transplantation come from live donors (relatives up to 4th degree) or cadavers. For example cornea and kidneys form the patient who died from heart disease can be transplanted to a blind patient or patient with renal deficiency. In patients with advanced heart, liver or renal insufficiencies healthy life is only possible with organ transplantations.

6843 Times viewed

Treatment without Touching the Eye with No-Touch Excimer Las...

In classical laser therapy that have been performed to get rid of eyeglasses and contact lens for a long time, your eye is necessarily touched. There is no device contact to eye in the laser therapy that is performed with laser method, called as TransPRK (No Touch) technique. Looking at the distant light source within seconds is sufficient to perform the therapy.

5597 Times viewed


Medical Park International

Orthopedics and Traumatology and 52 more

Landline: +90 212 227 1100
Landline: +90 444 44 84
E-mail: international@medicalpark.com.tr